Cite
Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness.
MLA
Boufraqech, Myriem, et al. “Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness.” Thyroid : Official Journal of the American Thyroid Association, vol. 29, no. 1, Jan. 2019, pp. 79–92. EBSCOhost, https://doi.org/10.1089/thy.2018.0424.
APA
Boufraqech, M., Patel, D., Nilubol, N., Powers, A., King, T., Shell, J., Lack, J., Zhang, L., Gara, S. K., Gunda, V., Klubo-Gwiezdzinska, J., Kumar, S., Fagin, J., Knauf, J., Parangi, S., Venzon, D., Quezado, M., & Kebebew, E. (2019). Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness. Thyroid : Official Journal of the American Thyroid Association, 29(1), 79–92. https://doi.org/10.1089/thy.2018.0424
Chicago
Boufraqech, Myriem, Dhaval Patel, Naris Nilubol, Astin Powers, Timothy King, Jasmine Shell, Justin Lack, et al. 2019. “Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness.” Thyroid : Official Journal of the American Thyroid Association 29 (1): 79–92. doi:10.1089/thy.2018.0424.